CLINICAL INTERVENTIONS IN AGING, cilt.9, ss.141-145, 2014 (SCI-Expanded)
Purpose: To describe 1-year clinical results of intravitreal ranibizumab treatment in patients with choroidal neovascularization secondary to exudative age-related macular degeneration (AMD) and to evaluate whether early treatment is a predictive value for prognosis of the disease.